Abiomed Inc. (ABMD): Price and Financial Metrics

Abiomed Inc. (ABMD): $381.02

0.23 (+0.06%)

POWR Rating

Component Grades








ABMD Price/Volume Stats

Current price $381.02 52-week high $381.99
Prev. close $380.79 52-week low $219.85
Day low $380.51 Volume 20,612,200
Day high $381.28 Avg. volume 611,028
50-day MA $343.62 Dividend yield N/A
200-day MA $291.25 Market Cap 17.18B

ABMD Stock Price Chart Interactive Chart >

Abiomed Inc. (ABMD) Company Bio

Abiomed is a publicly-traded medical device technology company that develops and manufactures temporary external and implantable mechanical circulatory support devices. The company is headquartered in Danvers, Massachusetts with additional offices in WoburnBaltimoreBerlinAachen, and Tokyo. Michael R. Minogue is Chairman, CEO & President of the company, with Dr. Thorsten Siess as Chief Technology Officer and Dr. Chuck Simonton as Chief Medical Officer. According to Bloomberg, the company "engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides continuum of care to heart failure patients". As of 2022, the company had secured five FDA approvals and 1,408 patents with 1,416 pending. For fiscal year 2022, Abiomed reported $1.032 billion in revenue and reported diluted earnings per share was $2.98 for the year. (Source:Wikipedia)

ABMD Latest News Stream

Event/Time News Detail
Loading, please wait...

ABMD Latest Social Stream

Loading social stream, please wait...

View Full ABMD Social Stream

Latest ABMD News From Around the Web

Below are the latest news stories about ABIOMED INC that investors may wish to consider to help them evaluate ABMD as an investment opportunity.

FDA Approves Impella ECP Pivotal Heart Pump and First Patients Enrolled in Pivotal Clinical Trial

DANVERS, Mass., December 21, 2022--Abiomed Announces First Patients Enrolled in FDA Pivotal Trial for Impella ECP, World’s Smallest Heart Pump

Yahoo | December 21, 2022

Steel Dynamics Set to Join S&P 500; Super Micro Computer to Join S&P MidCap 400

S&P MidCap 400 constituent Steel Dynamics Inc. (NASD:STLD) will replace Abiomed Inc. (NASD:ABMD) in the S&P 500 and Super Micro Computer Inc. (NASD:SMCI) will replace Steel Dynamics in the S&P MidCap 400 effective prior to the opening of trading on Thursday, December 22. S&P 500 constituent Johnson & Johnson (NYSE: JNJ) is acquiring Abiomed in a deal expected to close soon pending final conditions.

Yahoo | December 19, 2022

10 Best Performing Stocks in November

In this article, we discuss the 10 best performing stocks in November. If you want to read about some more best performing stocks in November, go directly to 5 Best Performing Stocks in November. After the eventful month of October, which is widely known for stock market crashes, the United States (US) stock market jumped […]

Yahoo | December 13, 2022

The 3 Best Funds to Buy for a Roth IRA

Looking to start an after-tax-funded individual retirement account?

Will Ashworth on InvestorPlace | December 12, 2022

Abiomed stock ticks higher after HSR waiting period for J&J sale expires

Abiomed (ABMD) ticked up 1% in premarket trading after the antitrust waiting period for its sale to Johnson & Johnson (JNJ) expired.The required waiting period under the HSR act expired…

Seeking Alpha | December 8, 2022

Read More 'ABMD' Stories Here

ABMD Price Returns

1-mo N/A
3-mo N/A
6-mo N/A
1-year N/A
3-year 8.54%
5-year 42.10%
2023 N/A
2022 0.00%
2021 10.79%
2020 90.05%
2019 -47.52%

Continue Researching ABMD

Here are a few links from around the web to help you further your research on Abiomed Inc's stock as an investment opportunity:

Abiomed Inc (ABMD) Stock Price | Nasdaq
Abiomed Inc (ABMD) Stock Quote, History and News - Yahoo Finance
Abiomed Inc (ABMD) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!